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Background: Ascorbic acid demonstrates a cytotoxic effect by generating hydrogen peroxide, a reactive oxygen
species (ROS) involved in oxidative cell stress. A panel of eleven human cancer cell lines, glioblastoma and
carcinoma, were exposed to serial dilutions of ascorbic acid (5-100 mmol/L). The purpose of this study was to
analyse the impact of catalase, an important hydrogen peroxide-detoxifying enzyme, on the resistance of cancer
cells to ascorbic acid mediated oxidative stress.
Methods: Effective concentration (EC50) values, which indicate the concentration of ascorbic acid that reduced the
number of viable cells by 50%, were detected with the crystal violet assay. The level of intracellular catalase protein
and enzyme activity was determined. Expression of catalase was silenced by catalase-specific short hairpin RNA
(sh-RNA) in BT-20 breast carcinoma cells. Oxidative cell stress induced apoptosis was measured by a caspase
luminescent assay.
Results: The tested human cancer cell lines demonstrated obvious differences in their resistance to ascorbic acid
mediated oxidative cell stress. Forty-five percent of the cell lines had an EC50> 20 mmol/L and fifty-five percent had
an EC50< 20 mmol/L. With an EC50 of 2.6–5.5 mmol/L, glioblastoma cells were the most susceptible cancer cell lines
analysed in this study. A correlation between catalase activity and the susceptibility to ascorbic acid was observed.
To study the possible protective role of catalase on the resistance of cancer cells to oxidative cell stress, the
expression of catalase in the breast carcinoma cell line BT-20, which cells were highly resistant to the exposure to
ascorbic acid (EC50: 94,9 mmol/L), was silenced with specific sh-RNA. The effect was that catalase-silenced BT-20
cells (BT-20 KD-CAT) became more susceptible to high concentrations of ascorbic acid (50 and 100 mmol/L).
Conclusions: Fifty-five percent of the human cancer cell lines tested were unable to protect themselves against
oxidative stress mediated by ascorbic acid induced hydrogen peroxide production. The antioxidative enzyme
catalase is important to protect cancer cells against cytotoxic hydrogen peroxide. Silenced catalase expression
increased the susceptibility of the formerly resistant cancer cell line BT-20 to oxidative stress.* Correspondence: Otto_c@chirurgie.uni-wuerzburg.de
1Experimental Surgery, Department of Surgery, University of Würzburg Hospital, Oberdürrbacher Str. 6, D-97080 Würzburg, Germany
Full list of author information is available at the end of the article
© 2012 Klingelhoeffer et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1 Panel of human cell lines tested in this study
Cell line Cell line
23132/87 gastric carcinoma HT-29 colon carcinoma
SKOV-3 ovarian carcinoma BXPC-3 pancreas carcinoma
BT-20 breast carcinoma MCF-7 breast carcinoma
U-13898 glioblastoma MDA-MB-468 breast carcinoma
U-87 glioblastoma MDA-MB-231 breast carcinoma
U-251 glioblastoma
HUVEC endothelial cells NHDF fibroblasts
The cells were purchased from different suppliers, e.g. American Type Culture
Collection (www.atcc.org), Health Protection Agency Culture Collection (www.
hpacultures.org.uk), German Collection of Microorganism and Cell Culture
(www.dsmz.de) and PromoCell (www.promocell.com).
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Ascorbic acid (vitamin C), an essential nutrient for mam-
malian cells, acts as a cofactor of different enzymatic
reactions, e.g. collagen synthesis. In addition, ascorbic
acid has an important impact on oxidative stress caused
by reactive oxygen species (ROS). Some of the most
common ROS are superoxide anion, hydroxide radical
and hydrogen peroxide [1]. The production of ROS is an
inevitable outcome of aerobic respiration in mitochon-
dria where oxygen acts as electron acceptor. Distur-
bances in aerobic respiration can lead to oxidative stress
by the production of ROS, resulting in cellular senes-
cence and apoptosis [2,3]. Antioxidant enzymes, part of
the physiological defence mechanisms in mammalian
cells against high concentrations of ROS, detoxify ROS
into less toxic or inert molecules [4,5]. One prominent
hydrogen peroxide-detoxifying enzyme is catalase.
Different studies showed a toxic effect of extracellular
ascorbic acid on a variety of cancer cell lines [6-9]. The
key to the anti-tumour effect of ascorbic acid is the pro-
duction of cytotoxic hydrogen peroxide [10,11]. Ascorbic
acid has many known interactions with metal ions, cata-
lysing its oxidation with concomitant formation of
hydrogen peroxide, among other things. [12,13]. Chen
et al. analysed the anticancer effect of extracellular ascor-
bic acid in pharmacological concentrations (up to
20 mmol/L), with the result that most cancer cells, but
not normal cells, were affected by 20 mmol/L ascorbic
acid, a concentration easily obtainable by intravenous
injection [9].
In this paper we present a panel of 11 human can-
cer cell lines, carcinomas and glioblastomas, in which
55% of the cell lines were more susceptible (EC50 ≤
20 mmol/L) and 45% were more resistant (EC50
>20 mmol/L) to the incubation with ascorbic acid. In
addition, the two benign cell types (endothelial cells and
fibroblasts) belong to the more resistant cell group. The
reason for the resistance of some tumour cell lines and
the benign cells to ascorbic acid mediated hydrogen per-
oxide production may be due to efficient antioxidant
defences. Immunohistochemistry has shown that cancer
cells can have elevated levels of antioxidant enzymes
[14], but many of them seem to be deficient in catalase
protein or catalase activity [15]. Therefore, the impact of
intracellular catalase on preventing oxidative stress
mediated by hydrogen peroxide must be analysed in
more detail. We found that the 3 glioblastoma cell lines
are extremely susceptible to ascorbic acid revealed
reduced activity of intracellular catalase. In contrast, as-
corbic acid resistant cancer cell lines, for example the
breast carcinoma cell line BT-20, exhibited increased
catalase protein and enzymatic activity. A catalase
knockdown in BT-20 cells sensitized them to the toxic
effect of extracellular ascorbic acid. The results indicatethat catalase is important for the resistance of cancer
cells to oxidative stress mediated by hydrogen peroxide.
Material and methods
Cell lines and reagents
Eleven malignant and 2 benign human cell lines were
tested (Table 1). Cells were cultured at a cell density of
1.5 × 104 cells per well of a 96-well plate at 37°C in 5%
CO2 in their recommended growth media containing 10%
FCS, 2 mmol/L glutamine (Invitrogen) and treated with
ascorbic acid (5, 10, 15, 20, 25, 50, 100 mmol/L, pH 7;
Sigma-Aldrich) for 14 h (Figure 1). Subsequently the
medium was removed, the cells were washed once and
cultured in growth medium without ascorbic acid for an
additional 10, 34 and 58 h (Figure 1). Ascorbic acid was
buffered to pH 7.0 with sodium hydroxide and prepared
immediately before use. Selected cell lines (BT-20, SKOV-
3, 23132/87, U-251, U-87) were also exposed to serial dilu-
tions (10, 50, 100, 200 μmol/L) of hydrogen peroxide
(Sigma-Aldrich) for 2 h. The medium was then removed
and cells were washed and cultured in growth medium for
an additional 22 h without hydrogen peroxide.
Measurement of cytotoxicity
Effective concentration (EC50) values, which indicate the
concentration of ascorbic acid that reduced the number
of viable cells by 50%, were determined after culture
(Figure 1) by the crystal violet assay [16]. This assay is
based on the photometric measurement of crystal violet,
which bonds at the DNA of viable cells. The measured
OD values at a wave length of 570 nm are directly pro-
portional to the number of viable cells. Data are pre-
sented as the mean± standard deviation of hexaplicates
for each ascorbic acid concentration. The experiments
were repeated independently three times each.
Determination of catalase levels
The level of catalase protein expression was detected by
western blot analysis in the following cell lines: BT-20,
SKOV-3, 23132/87, U-251, U-87. Cell pellets were lysed
Time (hours)
14 24 27840
Incubation
with
ascorbic acid
Exposure time Culture time
Exchange 
culture medium
(drug-free)
CV Assay
CV Assay
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Decrease of cell viability
Increase of ascorbic acid
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Figure 1 The experimental design for measuring the ascorbic acid mediated cytotoxic effect. (A) Cells in logarithmic growth phase were
exposed to serial dilutions of ascorbic acid (5-100 mmol/L) for 14 h (exposure time). Afterwards, the cells were washed and cultured in cultured
medium free of ascorbic acid, for 10, 34 and 58 h. (B) The number of viable cells was measured after culture by crystal violet (CV) staining with an
ELISA reader.
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Fisher Scientific). Protein concentration was determined
by Bradford Assay (Pierce) and 20 μg of protein per slot
was separated by SDS/Page and subsequently transferred
onto nitrocellulose membrane (Whatman, GE Health-
care). Protein transfer was confirmed with the prestained
protein ladder from Fermentas, Life Science (#SM0671).
A polyclonal anti-human catalase antibody (diluted 1:200
(#sc-34282) Santa Cruz Biotechnology) and anti-human
β-actin (diluted 1:200 (#sc-130301) Santa Cruz) were
used as primary antibody, and a donkey anti-goat IgG
secondary antibody coupled to horseradish peroxidase
(1:20,000 (#sc-2020) Santa Cruz) was applied for one
hour at room temperature. The enhanced chemilumines-
cent reagent ECL was used for detection (Amersham,
GE Healthcare). Immunoblots were scanned and ana-
lysed by using Image J program provided by the National
Institutes of Health. Relative expression level was deter-
mined by densitometry and normalized to the expression
of β-actin.
Inhibition of catalase gene expression by short hairpin
RNA (sh-RNA)
Expression of catalase was knocked down with Q-tech
by SIRION Biotech (www.sirion-biotech.de). Expression
of catalase (NM_001752) was silenced in BT-20 cells by
sh-RNA after transducing with adenoviral vector Ad-
shCAT under the control of the human U6 promotor(performed by SIRION Biotech). BT-20 Ctrl cells were
transduced with Q-tech control vector containing the
non-target (NT) sh-RNA sequence CAACAAGATGAA-
GAGCACCAA. Virus production was carried out in
HEK 293 cells.
Catalase activity assay
Catalase activity was determined with a commercially
available assay kit and was performed according the manu-
facture’s instructions (www.cellbiolabs.com). Cell Biolabs’
OxiSelect Catalase Activity Assay (#STA-341) involves two
reactions. Cells were harvested with a rubber policeman
and collected by centrifugation (2000 xg for 10 min at 4°
C). The cell pellets were sonicated in 1 ml cold PBS and
centrifuged at 10,000 xg for 15 min at 4°C. Twenty μl of
supernatant were used for the assay. The first reaction is
the catalase induced decomposition of known amounts of
hydrogen peroxide into water and oxygen. The remaining
hydrogen peroxide in the reaction mixture mediates a sec-
ond reaction with a chromogenic reagent to a quinonei-
mine dye coupling product measuring at 520 nm. The rate
of hydrogen peroxide disintegration is proportional to the
concentration of catalase. Catalase activity was calculated
with the following formula: B/30 × V × sample dilution
factor =nmol/min/ml =mU/ml; B is the amount of
decomposed hydrogen peroxide from hydrogen peroxide
standard curve in mmol/L and V is the pretreated sample
volume in ml added into the reaction; 30 is the reaction
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concentration (determined by Bradford Assay) and
expressed as mU per 100 μg of protein.
Determination of caspase activity
The Caspase-Glo 3/7 luminescent assay was performed
according the manufacture’s instructions (www.promega.
com). These members of the cysteine aspartic acid-spe-
cific protease (caspase) family play key effector roles in
apoptosis in mammalian cells. The assay provides a pro-
luminescent caspase-3/7 substrate, which contains the
tetrapeptide sequence DEVD. This substrate is cleaved to
release aminoluciferin, a substrate of luciferase used in
the production of light. The generated luminescent sig-
nal is proportional to caspase-3/7 activity and was mea-
sured with a luminometer (Genios Pro; Tecan,
Switzerland).
Statistical analysis
GraphPad Prism 4.0 software (Statcon, Witzenhausen,
Germany) was used for statistical analyses. Data were
analysed by Mann-Whitney U test to show significant
differences between the groups after the nonparametric
rank variance test of Puri and Sen. Probability values
below 0.05 were considered significant.
Results
The cytotoxic effect of ascorbic acid on different human
cancer cell lines
The toxic effect of ascorbic acid was analysed on 11
malignant and 2 benign cell lines (Table 1). For this
purpose, the cells were exposed to ascorbic acid in vitro
for 14 h, subsequently the medium was removed and0 10 20 30 40
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Figure 2 Relative cytotoxicity of ascorbic acid on cancer and benigne
acid exposure time of 14 h and an ascorbic acid free culture time of 34 h. C
culture. The results shown are representative for 3 independent analyses.the cells were cultured without ascorbic acid for an add-
itional 10, 34 and 58 h (Figure 1) to determine the con-
centration that decreased cell survival to 50% (EC50).
The tested cell lines demonstrated obvious differences in
their resistance to ascorbic acid (Figure 2). Five cancer
cell lines had an EC50> 20 mmol/L (up to 20 mmol/L:
the possible pharmacological concentration available by
intravenous injection [9]) and within this group the 3
cell lines SKOV-3, 23123/87, and BT-20 demonstrated
an EC50> 79 mmol/L (Table 2). A moderate EC50 be-
tween 20 and 79 mmol/L was determined for the 2 can-
cer cell lines BXPC-3, and HT-29. Six cancer cell lines
exhibited an EC50< 20 mmol/L: U-251, U-87, U-13898,
MDA-MB-468, MCF-7, and MDA-MB-231. The origin
of the cancer cells did not explain their susceptibility to
ascorbic acid mediated cytotoxicity. While the breast car-
cinoma cell line BT-20 was highly resistant to the expos-
ure to ascorbic acid (EC50: 94.9 mmol/L), the breast
carcinoma cell lines MDA-MB-231 (EC50: 12.2 mmol/L)
and MDA-MB-468 (EC50: 7.5 mmol/L) were more sus-
ceptible. Fibroblasts and endothelial cells demonstrated
EC50 values of 38.6 and 63.7 mmol/L, respectively
(Figure 2).
Ascorbic acid resistant human cancer cell lines are
cross-resistant to hydrogen peroxide
The toxicity of extracellular ascorbic acid is caused by
the generation of hydrogen peroxide [10,11]. The ascor-
bic acid induced generation of extracellular hydrogen
peroxide was successfully detected (not shown). There-
fore, cancer cells lines resistant to the ascorbic acid
mediated cytotoxic effect should also be more resistant
to the toxic effect of hydrogen peroxide than ascorbic50 60 70 80 90 100
orbic acid (mmol/L)
94.9
89.0
79.4
63.7
49.2
cells. Shown are the EC50 values of different cell lines for an ascorbic
ell viability was measured with the crystal violet assay at the end of
Table 2 Relative cytotoxicity of ascorbic acid and
hydrogen peroxide (H2O2) on cancer cells
Cell line EC50 ascorbic
acid (mmol/L)
EC50 H2O2
(μmol/L)
BT-20 94.9 241,2
SKOV-3 79.4 172,0
23132/87 89.0 165,5
U-87 2.8 96.6
U-251 2.6 77.1
Five cancer cell lines, characterized by their different susceptibility to the
ascorbic acid-mediated cytotoxic effect based on the generation of hydrogen
peroxide, were analysed for their susceptibility to hydrogen peroxide-mediated
cytotoxicity.
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the 3 cancer cell lines BT-20, SKOV-3, 23132/89, more
resistant to the toxic effect of ascorbic acid, and the 2
sensitive cell lines U-251, and U-87 were incubated with
different concentrations of hydrogen peroxide. The can-
cer cell line BT-20, highly resistant to the toxic effect
mediated by ascorbic acid, was also highly resistant to
the toxic effect mediated by hydrogen peroxide (Table 2).
In contrast, the glioblastoma cell lines U-251 and U-87,
extremely susceptible to the ascorbic acid mediated cyto-
toxic effect (EC50< 5.0 mmol/L), were most sensitive to
hydrogen peroxide, too (Table 2).
Adding exogenous catalase to glioblastoma cell lines
protected them against the toxic effect of ascorbic acid.
The glioblastoma cell line U-251, extremely sensitive to
the exposure to ascorbic acid (EC50: 2.6 mmol/L), was
incubated with 10 mmol/L ascorbic acid, the toxic con-
centration for this cell line, and different concentrations
of catalase (250 - 1000 U/mL) for 4 h. The cells were
subsequently cultured for 20 h before measuring cell0 1000 500
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Pe
rc
en
t o
f v
ia
bl
e 
ce
lls
125
75
25
100
Incubation with 10 mmol/L ascorbi
**
Figure 3 The hydrogen peroxide scavenger catalase prevents the cyto
production. The addition of exogenous catalase to cells of the U-251 cell l
prevented the lethal effect elicited by ascorbic acid. U-251 cells incubated w
shown are representative for 3 independent analyses and values are expres
between 0 and 250 units/mL catalase is significant (p= 0.004). N.s.: not signviability. The presence of exogenous catalase during ex-
posure time (Figure 1) prevented the toxic effect of both
ascorbic acid (Figure 3) and hydrogen peroxide (not
shown). The same results were obtained for the cell line
U-87 (not shown).
Catalase protein and enzymatic activity in human cancer
cells correlate with an increased resistance to ascorbic
acid mediated cell toxicity
The addition of exogenous catalase to ascorbic acid sus-
ceptible cancer cell lines neutralizes the cytotoxic effect of
ascorbic acid. Therefore, we investigated the assumption
that ascorbic acid resistant cells protect themselves by in-
creasing expression of intracellular catalase. For this, the 5
cell lines BT-20, SKOV-3, 23132/89, U-251, and U-87,
characterized by different sensitivities to ascorbic acid,
were examined concerning the catalase protein levels by
immunoblot. Compared to other cancer cell lines, the level
of catalase protein was significantly higher in BT-20 cells
highly resistant to the ascorbic acid mediated cytotoxic ef-
fect compared to the other cancer cell lines (Figure 4).
Since protein expression does not always correlate directly
with enzymatic activity, an enzymatic assay was used to
determine catalase activity. Catalase activity in the ascorbic
acid resistant cell lines SKOV-3, 23132/87 and BT-20 was
significantly increased in comparison to catalase activity
measured in the ascorbic acid non-resistant cell lines U-87
and U-251 (Figure 4B).
Silencing catalase expression in BT-20 cancer cells
increased their susceptibility to the toxicity of ascorbic
acid
To study the possible protective role of catalase in ascor-
bic acid resistant cancer cell lines, the expression of0250 1000
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Figure 4 Catalase protein and enzymatic activity in ascorbic acid resistant and susceptible cells. (A) Immunoblots and densitometric
analyses of catalase protein, and (B) enzymatic activity in ascorbic acid resistant cancer cell lines (BT-20, 23132/87, SKOV-3) and ascorbic acid
susceptible cancer cell lines (U-251, U-87). The protein level of catalase in ascorbic acid resistant BT-20 cells is significantly different (p< 0.001) to
the levels in 23132/87, SKOV-3 and the ascorbic acid susceptible cell lines U-251, U-87. There is a correlation between catalase activity and
resistance to the ascorbic acid mediated cytotoxic effect. The results shown are representative for 3 independent analyses. Values are expressed as
mean± standard deviation and significant differences (p ≤ 0.01) are shown (**) compared to U-251 and U-87, respectively.
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carcinoma cell line BT-20 with specific sh-RNA. BT-20
control cells (BT-20 Ctrl) was transduced with a control
vector coding for non-target sh-RNA. The knock-down
effect of sh-RNA transduction on the expression of cata-
lase protein was proved by western blot (Figure 5). The
maximum level of catalase knock-down was found to be
90% with RT-qPCR (not shown) and 95% in western blot
(Figure 5A). In addition, the catalase enzymatic activity
was reduced> 97% by knock-down (Figure 5B). BT-20
KD-CAT cells, BT-20 Ctrl cells and BT-20 wild type cells
did not demonstrate obvious differences in cell morph-
ology and cell growth (not shown).
Catalase knock-down in BT-20 cells (BT-20 KD-CAT
cells) was associated with increased susceptibility to the
ascorbic acid mediated toxic effect (Figure 6). The BT-
20 KD-CAT cells can be protected by external catalase
against the toxic effect of both ascorbic acid and hydro-
gen peroxide acid (not shown). An ascorbic acid con-
centration of 50 mmol/L did not influence BT-20 Ctrl
cells (Figure 6) and BT-20 wild type cells (Figure 2) but
increased cell death in BT-20 KD-CAT cells (Figure 6).
BT-20 cells are strongly resistant to ascorbic acid
mediated oxidative stress (EC50: 94.9 mmol/L) and in
the presence of 100 mmol/L ascorbic acid the cell via-
bility of BT-20 KD-CAT cells decreased stronger than
the viability of BT-20 Ctrl cells (Figure 6) and BT-20wild type cells. However, a low percentage (< 20%) of
BT-20 KD-CAT cells remained viable. We found that
the enzyme activity of glutathione peroxidase, the sec-
ond peroxide-detoxifying enzyme, was not influenced
by catalase knock-down (Additional file 1: Figure S1).
Therefore, we hypothesize that the remaining viability of
BT-20 KD-CAT cells and BT-20 Ctrl cells was caused by
the activity of glutathione peroxidase. Nevertheless, the
data presented suggest that catalase plays an important
role in the resistance to ascorbic acid mediated oxidative
stress. In addition, the susceptible BT-20 KD-CAT cells
demonstrated significantly higher caspase 3 and 7 activity
in the presence of 50 and 100 mmol/L ascorbic acid in
comparison to BT-20 Ctrl cells (Figure 7). These find-
ings demonstrate that inhibition of catalase in strongly
resistant BT-20 cells (BT-20 KD-CAT cells) sensitizes
them to ascorbic acid mediated oxidative stress and
increases the rate of apoptosis.
Discussion
The key to the anti-tumour effect of ascorbic acid is the
production of cytotoxic hydrogen peroxide [10,11]. In
this study a panel of 11 human cancer cell lines was
tested for their susceptibility to ascorbic acid. Three glio-
blastoma cell lines and the 3 breast carcinoma cell lines
demonstrated EC50 values< 20 mmol/L and were obvi-
ously susceptible to ascorbic acid mediated cytoxtoxicity.
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Figure 6 Catalase-silenced BT-20 KD-CAT cells are sensitized to the toxic effect of ascorbic acid. BT-20 KD-CAT cells were significantly
more affected by the exposure to high concentrations of ascorbic acid (50 and 100 mmol/L) than BT-20 Ctrl cells. The results shown are
representative for 3 independent analyses. Values are expressed as mean± standard deviation. *p< 0.01.
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Figure 5 Catalase-silencing influenced catalase expression and activity in BT-20 KD-CAT cells. (A) Catalase knock-down by sh-RNA was
proofed by western blot. (B) BT-20 KD-CAT cells demonstrated strongly reduced catalase activity in contrast to BT-20 wild type cells (BT-20 WT)
and BT-20 control cells (BT-20 Ctrl) transduced with Q-tech control vector containing the non-target sh-RNA sequence
CAACAAGATGAAGAGCACCAA. The results shown are representative for 3 independent analyses.
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Figure 7 Catalase-silenced BT-20 KD-CAT cells demonstrate increased caspase activity in the presence of ascorbic acid. BT-20 KD-CAT
cells and BT-20 Ctrl cells demonstrated significant differences in caspase activity in the presence of 50 mmol/L and 100 mmol/L ascorbic acid. At
lower concentration (10 mmol/L), there were no significant differences (data not shown). The results shown are representative for 3 independent
analyses. Values are expressed as mean± standard deviation and significant differences are shown.
Klingelhoeffer et al. BMC Complementary and Alternative Medicine 2012, 12:61 Page 8 of 10
http://www.biomedcentral.com/1472-6882/12/61Five of 11 carcinoma cells lines with EC50 values> 20
mmol/L were only marginally influenced in their viability
by elevated ascorbic acid concentrations (Figure 2).
In accordance with previous studies [9-11,13], we
found a toxic effect of ascorbic acid based on the local
production of hydrogen peroxide. Cell lines, e.g. BT-
20, 23132/87, SKOV-3, with a natural resistance to the
incubation with ascorbic acid, also demonstrated a nat-
ural resistance to toxic effects mediated by hydrogen
peroxide (Table 2). In contrast, cell lines, e.g. U-251
and U-87, susceptible to the incubation with ascorbic
acid, were also more susceptible to the incubation with
hydrogen peroxide. In addition, ascorbic acid resistant
cancer cell lines are more able to protect themselves
with increased catalase enzymatic activity, in contrast to
ascorbic acid susceptible cancer cell lines (Figure 4B).
Catalase-silencing sensitizes BT-20 breast carcinoma
cells to ascorbic acid mediated cell death. In addition to
catalase, enzymes of the peroxidase family, e.g. glutathi-
one peroxidase, are also important for cell protection.
In the present study, expression of glutathione peroxid-
ase was also proofed for all tested cancer cell lines,
but the level of protein and enzymatic activity did not
strongly correlate with the resistance of cancer cell
lines to the ascorbic acid-mediated cytotoxic effect
(not shown). The catalase knock-down in BT-20-
KD-CAT cells did not influence glutathione peroxid-
ase activity (Additional file 1: Figure S1), suggesting thatglutathione peroxidase may not play a major role in pro-
tecting cancer cells against cytotoxic hydrogen peroxide.
Ascorbic acid is able to act as a strong electron dona-
tor by reducing iron ions (Fe3+ to Fe2+). These ions may
exist alone or bound on matrix metal proteins [12].
Other metal ions like Cu2+, Ti3+, Cr2+ or Co2+ can also
be used as an electron carrier. These ions can be oxi-
dized and donate their electrons on oxygen by generating
a superoxide anion (O2-). Superoxide dismutase catalyses
the reaction of O2- to hydrogen peroxide that can induce
apoptosis in different ways: blocking the activity of a
plasma membrane Na+/H+ exchange system leading to
reduced cytosolic pH values or attacking DNA, usually
by its conversion into DNA-damaging hydroxyl ion
(OH•) [17]. In the present study we found that extracel-
lular catalase prevented the cell toxic effect of ascorbic
acid and supported cell viability of ascorbic acid suscep-
tible cancer cell lines (Figure 3). Catalase catabolizes
hydrogen peroxide to water and oxygen and helps to
protect aerobic organisms against excessive hydrogen
peroxide production. The cytotoxic effect of extracellular
ascorbic acid is finally mediated by the development of
extracellular hydrogen peroxide which is membrane per-
meable [18]. In addition, it is well known that ascorbic
acid enters directly into the cell with sodium-dependent
vitamin C transporter (SVCT1 and SVCT2) and in its
oxidized form dehydro-ascorbic acid can be internalized
by hexose transporters GLUT 1, GLUT 3, and GLUT 4
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extra- and intracellular balance, depending on their pH-
value. The extracellular amount of ascorbic acid was
identified as the more important one, because ascorbic
acid has toxic effects on cells even if there is only little
expression of those transporters [9,20].
It seems that many cancers demonstrate substantially
lower catalase activity than normal tissues, allowing cancers
to generate a moderate intracellular level of oxidative stress
to aid their proliferation and survival [15,21]. It is known
that expression of catalase is regulated at message, protein
and activity levels [22]. We could show that the tumour cell
lines used in the present study are different in their catalase
activity. Szatrowski described that rapidly proliferating cells
such as cancer cells generate abnormally high hydrogen
peroxide levels. This and other factors increased oxidative
stress during neoplastic transformation and may promote
the selection of cells with modified (increased or decreased)
catalase activity. The modified catalase expression in cancer
cells remains puzzling but it seems that prolonged expos-
ure to reactive oxygen species (ROS) downregulates cata-
lase expression via hypermethylation of the catalase
promoter and, in addition, transcription factors seem to be
involved [23,24]. Catalase is also down-regulated in healthy
cells transformed with T-antigen of SV40 or Ras, although
the underlying mechanisms of this down-regulation are still
unknown [25]. Interestingly, it also has been observed that
catalase levels are modified in cancer cell lines resistant to
some chemotherapeutic agents or hydrogen peroxide
[26,27]. In summary, catalase expression is regulated in a
wide array of cellular processes.
The use of ascorbic acid in tumour therapy is a matter
of some controversy [28-31]. Nevertheless, ascorbic acid is
used in tumour therapy, especially when evidence based
medicine or supportive therapy fail [32,33]. Many conven-
tional and novel anti-cancer drugs have been reevaluated
for their association with ROS production. For instance,
doxorubicin is a redoxcycling anthracycline that gener-
ates ROS. Biologics can also induce apoptosis through
the generation of ROS. Rituximab, an anti-CD20 mono-
clonal antibody approved for the treatment of non-
Hodgkin’s lymphoma, induces a rapid and intense pro-
duction of ROS in human lymphoma cells [34]. Another
aspect of ROS is that they are able to provoke uncon-
trolled cell growth by overstimulation of MAP Kinases
signal transduction pathways [35-38]. Furthermore, ROS
can activate hypoxia induced factor 1 (HIF-1) that stimu-
lates the cells to gain energy from glucose under hypoxic
conditions. HIF-1 increases the expression of glycolysis
enzymes and additionally stimulates the development of
new blood vessels (neovascularisation) by increasing the
expression of angiogenic factors (e.g. VEGF) to enhance
oxygen supply [39,40]. Increased levels of ROS, however,
damage cell structure and function [40].On the basis of our data, we were able to show a cor-
relation between catalase activity and resistance of can-
cer cell lines to the ascorbic acid induced cytotoxic
effect. Moreover, catalase is significant for cell protection
against hydrogen peroxide. The ascorbic acid resistant
cell line BT-20 became more susceptible to ascorbic acid
after sh-RNA mediated catalase knock-down and the rate
of apoptosis increased in these cells.
Conclusions
The present study demonstrates great differences in the
ability of cancer cell lines to prevent cell damage induced
by increased levels of hydrogen peroxide induced by as-
corbic acid. Forty-five percent of the cancer cell lines
tested are not affected by ascorbic acid and hydrogen
peroxide, respectively. Higher levels of catalase activity
are found in cell lines that are more resistant to oxidative
stress than in more susceptible cancer cell lines. This ob-
servation underlines the heterogeneity of cancer cells
concerning their ability to prevent cell death induced by
oxidative stress. Therefore, anticancer therapies based on
increased generation of ROS are influenced in their effi-
cacy by the antioxidative defence potential of cancer
cells. In this context the results of the present study
underline the important function of catalase as an anti-
oxidative enzyme.
Additional file
Additional file 1: Figure S1. Glutathione peroxidase activity in
BT-20 KD-CAT cells, BT-20 control cells and BT-20 wild type cells.
The knock-down of catalase does not influence glutathione peroxidase
activity, suggesting that glutathione peroxide may not play a major role
in resistance to oxidative stress. Glutathione peroxidase was measured
with BioVision’s Glutathione Peroxidase Activity Assay (#K762-100)
according the manufacture’s instructions (www.biovision.com). For this,
one million cells were homogenized in 200 μl cold assay buffer on ice,
centrifuged at 10,000 xg for 15 min at 4°C and 50 μl of the supernatant
were used for the assay. Glutathione peroxidase reduces hydrogen
peroxide while oxidizing reduced glutathione (GSH) to oxidized
glutathione (GSSG). The generated GSSG is reduced to GSH with
consumption of NADPH by glutathione reductase. The decrease of
NADPH, measured at 340 nm, is proportional to glutathione peroxidase
activity. Glutathione peroxidase activity was normalized for protein
concentration (determined by Bradford Assay) and expressed as mU per
100 μg of protein. The results shown are representative for 3
independent analyses.
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